RMC No. 17-2024: Updated VAT-Exempt Medicines List for Cancer, Diabetes, Hypertension, Kidney Disease, Mental Illness, and Tuberculosis

RMC No. 17-2024 updates VAT-exempt medicines for key diseases, including inclusions and a hypertension medicine deletion tied to FDA publication. Pharmaceutical companies, drugstores, hospitals, clinics, and VAT-registered sellers of medicines must immediately verify whether the medicines they sell are affected by the latest FDA-endorsed updates to the VAT-exempt medicines list. RMC No. 17-2024 publishes the […]

RMC No. 19-2023: VAT Exemption Updates for FDA-Endorsed Medicines and Medical Devices Under TRAIN and CREATE

RMC No. 19-2023 confirms FDA-endorsed VAT-exempt medicine and medical device updates, with CREATE Act exemption effective from FDA publication date. Businesses selling, purchasing, importing, prescribing, distributing, or accounting for VAT-exempt medicines and medical devices must verify whether their products are included in the Food and Drug Administration’s updated VAT-exempt list, because VAT exemption under the […]

RMC No. 157-2022: Updated VAT-Exempt Medicines List for Mental Illness and COVID-19 Treatment Under the CREATE Act

RMC No. 157-2022 updates the VAT-exempt medicines list under the CREATE Act, covering certain mental illness and COVID-19 treatment medicines. Pharmacies, hospitals, clinics, drug distributors, and sellers of covered medicines must verify whether their products are included in the updated List of VAT-Exempt Medicines because the VAT exemption applies only from the date the Food […]

RMC No. 116-2022: Updated VAT-Exempt Medicines List for Hypertension, Diabetes, Kidney Disease, Mental Illness, Cancer, and Deleted COVID-19 Medicines

RMC No. 116-2022 updates the VAT-exempt medicines list under CREATE, adding certain chronic disease medicines and deleting some COVID-19 medicines. Pharmacies, hospitals, clinics, distributors, importers, and accounting teams handling medicines must immediately check whether their products remain VAT-exempt, newly qualify for VAT exemption, or have been removed from the VAT-exempt list. RMC No. 116-2022 confirms […]

RMC No. 68-2022: Updated VAT-Exempt Medicines List for Hypertension, Diabetes, Cancer, COVID-19 and Other Treatments

RMC No. 68-2022 updates the FDA-endorsed VAT-exempt medicines list under CREATE for key disease categories including COVID-19 and cancer. Pharmacies, hospitals, clinics, distributors, importers, and VAT-registered sellers of medicines must check whether their covered products are included in the updated VAT-exempt medicines list endorsed by the Food and Drug Administration, because qualifying medicines for hypertension, […]